Among them, the stilbene resveratrol holds considerable promise for clinical application as its treatment could promote cell death in many types of cancers, sensitise the resistant cancer cells to therapy, restore insulin secretion, alleviate diabetic complications, as well as protect against neuronal damage through modulation of autophagy. This evidence concerns the gene INS and cancer.